However, previous research has suggested that some cases of Parkinsons disease can be associated with problems with metabolic health, which is a measure of how the body deals with sugar, fat, and manages blood pressure
Dr Marie Spreckley, from the Medical Research Council (MRC) Epidemiology Unit at the University of Cambridge, said: Use of GLP-1 receptor agonist therapies has increased rapidly in a very short period of time, but the nutritional support available to people using these medications has not kept pace
But the GLP-1 boom has created an opportunity for compounders that has transformed pockets of the industry, with compounding pharmacies producing off-brand duplicates for likely millions of patients
SR and mitochondria: calcium cross-talk between kissing cousins
This protection extends to telomeres the protective caps on our chromosomes that shorten with age